NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 23 of 23 results found.

Activity Company Description Location
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Chapel Hill
Company CLAIRIgene LLC Activity: Research and Development Research and Development Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Creyon Bio Activity: Research and Development Research and Development Company Description Creyon Bio is a drug development company engineering RNA-based medicines and their components. Location Research Triangle Park
Company Denizen Biologics LLC Activity: Research and Development Research and Development Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. Location Cary
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Morrisville
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. Location Morrisville
Company FastBack Bio LLC Activity: Research and Development Research and Development Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. Location Raleigh
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. Location Raleigh
Company GENIE Therapeutics Activity: Research and Development Research and Development Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. Location Winston-Salem
Company Immorna Biotherapeutics Inc. Activity: Research and Development Research and Development Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. Location Raleigh
Company Isolere Bio Inc. Activity: Research and Development Research and Development Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. Location Durham
Company NabGen Inc. Activity: Research and Development Research and Development Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. Location Durham
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Chapel Hill
Company Opus Genetics Inc. Activity: Research and Development Research and Development Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. Location Research Triangle Park
Company PhosphoGam Inc. Activity: Research and Development Research and Development Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. Location Durham
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Sarepta Therapeutics Inc. (Durham) Activity: Research and Development Research and Development Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. Location Durham
Company SNP Therapeutics LLC Activity: Research and Development Research and Development Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. Location Kannapolis
Company Torque Bio Inc. Activity: Research and Development Research and Development Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. Location Durham